Dr. Edith Perez Discusses the Adjuvant Treatment of Breast Cancer OncLive 1:04 11 years ago 130 Скачать Далее
Dr. Edith Perez Discusses Adjuvant Chemotherapy Patient Selection OncLive 1:15 12 years ago 215 Скачать Далее
Edith Perez, MD - Panelist (introduction) Breast Cancer Research Foundation 5:37 12 years ago 64 Скачать Далее
Dr. Edith Perez Discusses BOLERO-1 Trial Results for HER2-Positive Breast Cancer OncLive 1:07 9 years ago 203 Скачать Далее
Dr. Edith Perez on the development of targeted therapies Breast Cancer Research Foundation 3:07 13 years ago 114 Скачать Далее
Dr. Edith Perez on the Etirinotecan Pegol for HER2-Negative Breast Cancer OncLive 1:20 9 years ago 401 Скачать Далее
Dr. Edith Perez Discusses Anti-HER2 Therapies -- 2012 SABCS Breast Cancer Answers® 16:17 11 years ago 3 064 Скачать Далее
"What is the Nektar trial for women with metastatic breast cancer?" Breast Cancer Research Foundation 1:32 11 years ago 69 Скачать Далее
Dr. Edith Perez Describes the Mayo Clinic Breast Cancer Translational Genomics Program OncLive 1:03 12 years ago 357 Скачать Далее
Dr. Edith Perez on Immune Checkpoint Inhibition in Triple-Negative Breast Cancer OncLive 1:25 9 years ago 619 Скачать Далее
Edith A. Perez, MD: Anti-HER2 Therapies Vital Options International 7:28 11 years ago 454 Скачать Далее
2010 SABCS Interview with Edith A. Perez, M.D. American Association for Cancer Research 4:57 13 years ago 401 Скачать Далее
Dr. Perez Discusses a Genomic Analysis of the NCCTG (Alliance) N9831 Adjuvant Trastuzumab Trial OncLive 1:16 10 years ago 137 Скачать Далее
Meet Dr. Edith Perez | Minority Health Month | Stand Up To Cancer Stand Up To Cancer 1:05 5 years ago 242 Скачать Далее
Dr. Perez Discusses a Genomic Analysis of the NCCTG N9831 Adjuvant Trastuzumab Trial Silas Inman 1:25 9 years ago 52 Скачать Далее
